Inno Care Pharma
Biotechnology, 103 Carnegie CTR Ste 209, Princeton, New Jersey, 08540, United States, 1001-5000 Employees
Who is INNOCARE PHARMA
InnoCare Pharma is a commercial stage biopharmaceutical company dedicated to discovering, developing, and commercializing best-in-class and/or first-in-class drugs for the treatment of ca...
Read More
-
Headquarters: 103 Carnegie CTR Ste 209, Princeton, New Jersey, 08540, United States
-
Date Founded: 2015
-
Employees: 1001-5000
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 28
|
NAICS Code: 32 |
Show More
Does something look wrong? Fix it. | View contact records from INNOCARE PHARMA
InnoCare Pharma Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding InnoCare Pharma
Answer: InnoCare Pharma's headquarters are located at 103 Carnegie CTR Ste 209, Princeton, New Jersey, 08540, United States
Answer: InnoCare Pharma's official website is https://innocarepharma.com
Answer: InnoCare Pharma's revenue is $1 Million to $5 Million
Answer: InnoCare Pharma's SIC: 28
Answer: InnoCare Pharma's NAICS: 32
Answer: InnoCare Pharma has 1001-5000 employees
Answer: InnoCare Pharma is in Biotechnology
Answer: InnoCare Pharma contact info: Phone number: Website: https://innocarepharma.com
Answer: InnoCare Pharma is a commercial stage biopharmaceutical company dedicated to discovering, developing, and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. InnoCare has strong in-house innovation capabilities, holding multiple foreign and domestic patents with a rich product pipeline target liquid tumors, solid tumors, and autoimmune diseases. Our team has discovered and developed a strong pipeline. InnoCare was co-founded by Professor Shi Yigong, a world-renowned structural biologist, and Dr. Cui Jisong, an outstanding leader in the biopharmaceutical industry. We have over 1000 employees. Our core R&D staff brings rich experience from the world's top pharmaceutical companies, such as Pfizer, GSK, Bristol-Myers Squibb, Merck, Johnson & Johnson, Bayer, etc. We are a truly global biopharmaceutical company with sites in Beijing, Nanjing, Shanghai, and Guangzhou, Hong Kong and Unites States. On March 23, 2020, InnoCare officially listed on the Hong Kong Stock Exchange (code: 9969). And on Sept. 21, 2023, InnoCare successfully got listed on STAR Board of Shanghai Stock Exchange (code: 688428). Our vision is to become a world-class biopharma leader to address the unmet medical needs globally.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month